Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2019 | 1 |
2021 | 1 |
2022 | 3 |
2023 | 3 |
2024 | 0 |
Search Results
7 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Integrative analysis of drug response and clinical outcome in acute myeloid leukemia.
Cancer Cell. 2022 Aug 8;40(8):850-864.e9. doi: 10.1016/j.ccell.2022.07.002. Epub 2022 Jul 21.
Cancer Cell. 2022.
PMID: 35868306
Free PMC article.
BET inhibitors rescue anti-PD1 resistance by enhancing TCF7 accessibility in leukemia-derived terminally exhausted CD8+ T cells.
Romine KA, MacPherson K, Cho HJ, Kosaka Y, Flynn PA, Byrd KH, Coy JL, Newman MT, Pandita R, Loo CP, Scott J, Adey AC, Lind EF.
Romine KA, et al.
Leukemia. 2023 Mar;37(3):580-592. doi: 10.1038/s41375-023-01808-0. Epub 2023 Jan 21.
Leukemia. 2023.
PMID: 36681742
Free PMC article.
Item in Clipboard
Rise of the Clones: Myelodysplastic Syndrome to Secondary Acute Myeloid Leukemia.
Romine KA, van Galen P.
Romine KA, et al.
Blood Cancer Discov. 2022 Jul 6;3(4):270-272. doi: 10.1158/2643-3230.BCD-22-0046.
Blood Cancer Discov. 2022.
PMID: 35709709
Free PMC article.
Item in Clipboard
Secondary fusion proteins as a mechanism of BCR::ABL1 kinase-independent resistance in chronic myeloid leukaemia.
Barnes EJ, Eide CA, Kaempf A, Bottomly D, Romine KA, Wilmot B, Saunders D, McWeeney SK, Tognon CE, Druker BJ.
Barnes EJ, et al. Among authors: romine ka.
Br J Haematol. 2023 Feb;200(3):323-328. doi: 10.1111/bjh.18515. Epub 2022 Oct 20.
Br J Haematol. 2023.
PMID: 36264026
Free PMC article.
Item in Clipboard
Monocytic differentiation and AHR signaling as Primary Nodes of BET Inhibitor Response in Acute Myeloid Leukemia.
Romine KA, Nechiporuk T, Bottomly D, Jeng S, McWeeney SK, Kaempf A, Corces MR, Majeti R, Tyner JW.
Romine KA, et al.
Blood Cancer Discov. 2021 Sep;2(5):518-531. doi: 10.1158/2643-3230.BCD-21-0012. Epub 2021 Jul 1.
Blood Cancer Discov. 2021.
PMID: 34568834
Free PMC article.
Item in Clipboard
Acute myeloid leukemia-induced T-cell suppression can be reversed by inhibition of the MAPK pathway.
Moshofsky KB, Cho HJ, Wu G, Romine KA, Newman MT, Kosaka Y, McWeeney SK, Lind EF.
Moshofsky KB, et al. Among authors: romine ka.
Blood Adv. 2019 Oct 22;3(20):3038-3051. doi: 10.1182/bloodadvances.2019000574.
Blood Adv. 2019.
PMID: 31648326
Free PMC article.
Item in Clipboard
Immune cell proportions correlate with clinicogenomic features and ex vivo drug responses in acute myeloid leukemia.
Romine KA, Bottomly D, Yashar W, Long N, Viehdorfer M, McWeeney SK, Tyner JW.
Romine KA, et al.
Front Oncol. 2023 Jun 8;13:1192829. doi: 10.3389/fonc.2023.1192829. eCollection 2023.
Front Oncol. 2023.
PMID: 37361575
Free PMC article.
Item in Clipboard
Cite
Cite